(Q27639923)

ORCID Public Data File 2021

author name string

Marlyse Buisson

1

0 references

Jean-François Hernandez

2

0 references

David Lascoux

3

0 references

Eric Forest

5

0 references

Gérard Arlaud

6

0 references

Jean-Marie Seigneurin

7

0 references

Rob W H Ruigrok

8

0 references

Wim P Burmeister

Journal of Molecular Biology

9

0 references

language of work or name

English

0 references

publication date

15 November 2002

0 references

published in

0 references

volume

324

0 references

issue

1

0 references

page(s)

89-103

0 references

cites work

Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Acyclovir for treatment of infectious mononucleosis: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

The herpesvirus proteases as targets for antiviral chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Assembly of the herpes simplex virus capsid: characterization of intermediates observed during cell-free capsid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

The herpes simplex virus procapsid: structure, conformational changes upon maturation, and roles of the triplex proteins VP19c and VP23 in assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Isolation of herpes simplex virus procapsids from cells infected with a protease-deficient mutant virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Evidence for controlled incorporation of herpes simplex virus type 1 UL26 protease into capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Capsids are formed in a mutant virus blocked at the maturation site of the UL26 and UL26.5 open reading frames of herpes simplex virus type 1 but are not formed in a null mutant of UL38 (VP19C).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Dimerization of the human cytomegalovirus protease: kinetic and biochemical characterization of the catalytic homodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Active human cytomegalovirus protease is a dimer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Dimerization and activation of the herpes simplex virus type 1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Functional determinants of the Epstein-Barr virus protease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Unique fold and active site in cytomegalovirus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Three-dimensional structure of human cytomegalovirus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Crystal structure of varicella-zoster virus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Kinetic properties of human dopamine sulfotransferase (SULT1A3) expressed in prokaryotic and eukaryotic systems: comparison with the recombinant enzyme purified from Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

[81] Organophosphorus compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Structure of inhibited trypsin from Fusarium oxysporum at 1.55 A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Conformational change coupling the dimerization and activation of KSHV protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Recombinant full-length human cytomegalovirus protease has lower activity than recombinant processed protease domain in purified enzyme and cell-based assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Purification and kinetic characterization of human cytomegalovirus assemblin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

The CCP4 suite: programs for protein crystallography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Improved methods for building protein models in electron density maps and the location of errors in these models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Further additions to MolScript version 1.4, including reading and contouring of electron-density maps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

ESPript: analysis of multiple sequence alignments in PostScript

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Release of the catalytic domain N(o) from the herpes simplex virus type 1 protease is required for viral growth

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901040-9